ADHD Medication AZSTARYS Shown Safe and Effective in Long-Term Study

BOSTON, Feb. 22, 2023. Corium, LLC, a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, announced today publication of the results from a 12-month, open-label,...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials